Scotland opens door to Translarna for Duchenne muscular dystrophy
A disparity in UK access to a medicine for Duchenne muscular dystrophy (DMD) has been addressed, after Scotland gave a green light to use of PTC Therapeutics’ Translarna for the first time. The Scottish Medicines Consortium (SMC) says that Translarna (ataluren) can be provided by… Read More »Scotland opens door to Translarna for Duchenne muscular dystrophy